Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis

胆汁酸介导的 IQGAP1 调节驱动肝脏肿瘤发生

基本信息

批准号：
10160810
负责人：
Hanna Erickson
金额：
$ 4.46万
依托单位：
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-05-16 至 2022-02-15
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10160810
关键词：
Address Affect Age-Months Autopsy Bile Acids Binding Sites Biological Assay Cell Culture Techniques Cell Line Cell physiology Cell-Cell Adhesion Cells Cessation of life Chemical Models Chenodeoxycholic Acid Cholesterol Cholic Acids Cycloheximide Dactinomycin Data Dependence Development Diagnostic Diet Diethylnitrosamine Dose Epidermal Growth Factor Receptor FRAP1 gene Family Fatty acid glycerol esters Female Fibrosis GPBAR1 gene Gene Expression Genes Genetic Genetic Transcription Goals Gold Growth HNF4A gene HepG2 Hepatic Hepatocarcinogenesis Hepatocyte Histologic IQ motif containing GTPase activating protein 1 Immunofluorescence Immunologic In Vitro Incidence Inflammation Introns Kupffer Cells Laboratories Lesion Letters Ligands Link Lithocholic Acid Liver Liver diseases Liver neoplasms Luciferases Magnetic Resonance Imaging Malignant Neoplasms Malignant neoplasm of liver Mediating Messenger RNA Modeling Molecular Monitor Mus Necrosis Nuclear Receptors Pathway interactions Patients Prevalence Primary carcinoma of the liver cells Prognosis Prognostic Factor Proteins RNA Receptor Signaling Regulation Role Scaffolding Protein Sex Differences Signal Pathway Signal Transduction Site Testing Time Translations Tumor Promotion United States Work absorption angiogenesis base cancer cell cancer diagnosis cell motility cell type cohort deletion analysis design effective therapy extracellular in silico in vivo knock-down liver cell proliferation mRNA Expression male migration mouse model new therapeutic target novel therapeutics overexpression pregnane X receptor promoter protein activation protein expression pup receptor receptor binding response small hairpin RNA stellate cell therapeutic target transcription factor tumor tumor progression tumorigenesis

项目摘要

Project Summary/Abstract Hepatocellular carcinoma (HCC) is the second most lethal cancer worldwide, and its incidence is rapidly increasing in the United States. These findings underscore the immense need to identify new therapeutic as well as early diagnostic targets for HCC. Our laboratory previously discovered that bile acids, a family of endogenous cholesterol metabolites synthesized in the liver, were able to activate the pro-proliferative YAP (Yes-Associated Protein) signaling. Importantly, it was also found that this YAP activation is dependent on a scaffolding protein IQ motif-containing GTPase Activating Protein 1 (IQGAP1). In fact, overexpression of IQGAP1 is associated with a poor prognosis in a number of cancers including HCC. Consistent with this hypothesis, IQGAP1 is known to regulate and integrate numerous signaling pathways, which are commonly upregulated in cancer including ERK, YAP, mTOR, and EGFR. However, the regulation of IQGAP1 remains largely unknown. This proposal aims to identify the regulation and role for IQGAP1 during HCC development by determining (i) How do bile acids induce IQGAP1 expression? and (ii) What is the contribution of IQGAP1 in promoting liver tumor development? Bile acids signal primarily through nuclear receptors to increase transcription of target genes with farnesoid X receptor (FXR) being the major one to carry out the downstream effects of bile acids. Our preliminary data identified that increased BAs induced Iqgap1 mRNA in vitro in a dose-dependent manner. Interestingly, this Iqgap1 mRNA induction was mimicked when FXR was specifically activated by GW4064 treatment, suggesting that bile acids may activate Iqgap1 expression via FXR. The first aim of this proposal is to elucidate the BA receptor(s) and signaling pathway(s) responsible for IQGAP1. The second aim is focused on delineating the role for IQGAP1 in liver tumor development and determining if IQGAP1 is necessary to drive hepatic tumor promotion by bile acids. The robust diethylnitrosamine (DEN) mouse model of chemically induced liver tumorigenesis will be used to address this aim. Successful completion of this work will identify the mechanism for Iqgap1 regulation by bile acids and determine if manipulating IQGAP1 expression can be an effective strategy to limit the growth of liver tumors.

项目摘要/摘要肝细胞癌（HCC）是全球第二大致命的癌症，其发病率迅速在美国增加。这些发现强调了识别新治疗的巨大需求以及HCC的早期诊断目标。我们的实验室以前发现胆汁酸是一个内源性胆固醇代谢物在肝脏中合成，能够激活促增强的YAP （与是相关的蛋白质）信号传导。重要的是，还发现这种yap激活取决于脚手架蛋白IQ基序的GTPase激活蛋白1（IQGAP1）。实际上，过表达 IQGAP1与包括HCC在内的许多癌症的预后不良有关。与此一致假设，IQGAP1已知会调节和整合许多信号通路，这通常是在包括ERK，YAP，MTOR和EGFR在内的癌症中上调。但是，IQGAP1的调节仍然在很大程度上未知。该建议旨在确定HCC开发期间IQGAP1的法规和作用通过确定（i）胆汁酸如何诱导IQGAP1表达？（ii）IQGAP1在促进肝肿瘤发育？胆汁酸主要通过核受体发出信号以增加靶基因的转录Farnesoid X受体（FXR）是下游进行的主要靶基因胆汁酸的作用。我们的初步数据确定，在A中，BAS诱导的IQGAP1 mRNA升高剂量依赖性方式。有趣的是，当FXR专门时，对此IQGAP1 mRNA诱导进行了模仿通过GW4064处理激活，表明胆汁酸可以通过FXR激活IQGAP1表达。第一个该建议的目的是阐明负责IQGAP1的BA受体和信号通路。这第二个目标的重点是描述IQGAP1在肝肿瘤发育中的作用并确定是否是否 IQGAP1对于通过胆汁酸促进肝肿瘤是必要的。强大的二乙基硝基胺（DEN）化学诱导的肝肿瘤发生的小鼠模型将用于解决这一目标。成功的这项工作的完成将确定通过胆汁酸调节IQGAP1的机制，并确定是否是否操纵IQGAP1表达可能是限制肝肿瘤生长的有效策略。